Modifying muscle mass - the endocrine perspective

Area of Science:

• Endocrinology
• Muscle Physiology
• Molecular Biology

Background:

• Skeletal muscle mass is regulated by hormonal factors influencing anabolism and catabolism.
• Age-related muscle loss (sarcopenia) is a significant health concern with complex underlying mechanisms.
• Satellite cells play a crucial role in muscle hypertrophy and are influenced by local endocrine factors.

Purpose of the Study:

• To review the major hormonal factors governing skeletal muscle anabolism and catabolism.
• To examine the molecular mechanisms of muscle hypertrophy and atrophy, focusing on sarcopenia.
• To discuss novel endocrine mechanisms and potential therapeutic targets for muscle wasting.

Main Methods:

• Literature review of hormonal regulation in skeletal muscle.
• Analysis of molecular pathways involved in muscle hypertrophy and atrophy.
• Examination of the role of satellite cells and endocrine factors in muscle dynamics.

Main Results:

• Hormonal factors critically determine the balance between muscle protein synthesis and breakdown.
• Satellite cell dynamics are modulated by local endocrine signals, impacting muscle repair and growth.
• Mechanisms of muscle atrophy and hypertrophy may not be simple opposites; novel pathways like IGF-I subtypes are involved.
• Myostatin is identified as a key negative regulator of muscle mass with therapeutic potential.

Conclusions:

• Hormonal regulation is central to maintaining skeletal muscle mass and function throughout life.
• Understanding satellite cell biology and endocrine influences is key to addressing sarcopenia.
• Targeting pathways like myostatin offers promising therapeutic strategies for age-related muscle loss and other muscle disorders.